PRONOVA BIOPHARMA Trademark

Trademark Overview

On Tuesday, October 30, 2007, a trademark application was filed for PRONOVA BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the PRONOVA BIOPHARMA trademark a serial number of 79048575. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, February 26, 2021. This trademark is owned by Pronova BioPharma Norge AS. The PRONOVA BIOPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of metabolic, inflammatory and cardiovascular diseases; lipids for pharmaceutical purposes for use in the treatment of metabolic, inflammatory and cardiovascular diseases; substances with marine origin, namely, Omega 3 lipids for pharmaceutical purposes used in the treatment of metabolic, inflammatory and cardiovascular diseases
pronova biopharma

General Information

Serial Number79048575
Word MarkPRONOVA BIOPHARMA
Filing DateTuesday, October 30, 2007
Status709 - CANCELLED - SECTION 71
Status DateFriday, February 26, 2021
Registration Number3576375
Registration DateTuesday, February 17, 2009
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 2, 2008

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOPHARMA"
Description of MarkThe mark consists of the words "Pronova Biopharma" in a stylized format and a circular globe above the second "o" in "Pronova".
Goods and ServicesPharmaceutical preparations for use in the treatment of metabolic, inflammatory and cardiovascular diseases; lipids for pharmaceutical purposes for use in the treatment of metabolic, inflammatory and cardiovascular diseases; substances with marine origin, namely, Omega 3 lipids for pharmaceutical purposes used in the treatment of metabolic, inflammatory and cardiovascular diseases
Pseudo MarkPRONOVA BIOPHARMACEUTICAL

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBASF AS
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNO
Party NamePronova BioPharma Norge AS
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressN-1366 Lysaker
NO
Party NamePronova BioPharma Norge AS
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressN-1366 Lysaker
NO

Trademark Events

Event DateEvent Description
Friday, January 14, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, December 9, 2021TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, December 9, 2021INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Thursday, November 8, 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, February 17, 2018COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Thursday, November 16, 2017INTERNATIONAL REGISTRATION RENEWED
Thursday, August 27, 2015NEW REPRESENTATIVE AT IB RECEIVED
Thursday, January 8, 2015NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Thursday, January 8, 2015REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Thursday, January 8, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 8, 2014TEAS SECTION 71 & 15 RECEIVED
Friday, August 30, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 30, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 12, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, May 26, 2009FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, May 26, 2009FINAL DISPOSITION PROCESSED
Sunday, May 17, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 17, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, December 2, 2008PUBLISHED FOR OPPOSITION
Wednesday, November 12, 2008NOTICE OF PUBLICATION
Tuesday, October 28, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 22, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 22, 2008EXAMINER'S AMENDMENT ENTERED
Wednesday, October 22, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 22, 2008EXAMINERS AMENDMENT E-MAILED
Wednesday, October 22, 2008EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 14, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 14, 2008NON-FINAL ACTION E-MAILED
Tuesday, October 14, 2008NON-FINAL ACTION WRITTEN
Monday, September 22, 2008EXAMINER'S AMENDMENT ENTERED
Monday, September 22, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, September 22, 2008EXAMINERS AMENDMENT E-MAILED
Monday, September 22, 2008EXAMINERS AMENDMENT -WRITTEN
Friday, September 5, 2008NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, September 5, 2008FINAL REFUSAL E-MAILED
Friday, September 5, 2008FINAL REFUSAL WRITTEN
Friday, August 15, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 15, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 15, 2008ASSIGNED TO LIE
Tuesday, August 12, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 17, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 17, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 14, 2008REFUSAL PROCESSED BY IB
Wednesday, February 20, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, February 20, 2008REFUSAL PROCESSED BY MPU
Wednesday, February 20, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 19, 2008NON-FINAL ACTION WRITTEN
Tuesday, February 12, 2008ASSIGNED TO EXAMINER
Friday, February 8, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, February 7, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

biopharma pronova cardiovascular diseases inflammatory metabolic pharmaceutical treatment purposes lipids omega used